世界のジェネリック医薬品市場予測2021年-2026年

◆英語タイトル:Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
◆商品コード:IMA21AP098
◆発行会社(リサーチ会社):IMARC
◆発行日:2021年4月
◆ページ数:116
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD1,499 ⇒換算¥164,890見積依頼/購入/質問フォーム
Five UserUSD1,999 ⇒換算¥219,890見積依頼/購入/質問フォーム
EnterprisewideUSD2,499 ⇒換算¥274,890見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はIMARC社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
IMARC社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、世界のジェネリック医薬品市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、主要地域市場規模、治療別分析、薬物送達別分析、流通チャンネル別分析、競争状況、製造プロセス、プロジェクト詳細・規定・費用、ローン・金融援助、プロジェクト経済などを掲載しています。
【レポートの概要】

The global generic drugs market reached a value of US$ 386 Billion in 2020. A generic drug is a medicine that contains the same active ingredient and has an equivalent therapeutic effect as the branded drug. It is also identical in terms of safety, quality, dosage, strength, route of administration, intended use, effect, form, quality and side effects. These medications can be produced only after the patent expiration of the brand-name drug. As compared to branded drugs, the production of generics costs much less as it does not require the repetition of clinical (human) and animal studies to demonstrate the effectiveness and safety of the medicine. Due to a reduction in the upfront cost of research, generics are typically sold at a substantially lower price in the market.
Market Trends:

Due to an aging population and increasing incidences of chronic diseases, governments of developed countries have been making efforts to reduce healthcare costs by promoting the production of generics. Whereas, in developing countries, affordability and accessibility are some of the primary issues faced by the healthcare industry. To address these problems, governments and other regulatory bodies have been encouraging manufacturers to introduce effective generic drugs. However, despite the rapid patent expiry of branded drugs, there has been a shortage of generics. This situation is currently being rectified by various initiatives taken by hospitals, institutions and other organizations across the globe. For instance, in 2018, a coalition of seven hospitals and three philanthropies in the US announced that they would be addressing drug shortages and the high cost of essential medications by launching a generic drug company, named Civica Rx. The company is producing 14 short-supply, FDA-approved drugs that have been available in the market since the beginning of 2019. Other than this, in 2018, the United States Food and Drug Administration (USFDA) created policies to make the process of market entry and generic approval more efficient. It issued guidance documents for the development of both hard-to-copy drug categories and specific complex drugs. Looking forward, IMARC Group expects the global generic drugs market to exhibit moderate growth during the next five years.

Breakup by Therapy Area:

Central Nervous System
Cardiovascular
Dermatology
Genitourinary/Hormonal
Respiratory
Rheumatology
Diabetes
Oncology
Others
Cardiovascular diseases (CVDs) are the leading therapy area, accounting for the majority of the total market, on account of the increasing cases of CVDs as a result of unhealthy eating habits and sedentary lifestyles.

Breakup by Drug Delivery:

Oral
Injectables
Dermal/Topical
Inhalers
Currently, oral medicines are the most preferred product, owing to the convenience attached to their administration, which requires minimal to no medical assistance.

Breakup by Distribution Channel:

Retail Pharmacies
Hospital Pharmacies
At present, the majority of the generics are distributed through retail pharmacy stores as most generic drugs are over the counter (OTC) medicines that can be bought without a prescription.

Regional Insights:

United States
China
Brazil
Germany
France
India
United Kingdom
Japan
Canada
Italy
Others
On a regional basis, the United States represents the biggest market, accounting for the largest market share. This growth is led by numerous initiatives by the US Government to improve generic drug manufacturing and access in the country.

Competitive Landscape:

The market is fragmented in nature with the presence of various small and large manufacturers. Some of the leading players operating in the market include Teva Pharmaceuticals Industries Ltd., Mylan N.V., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Fresenius SE & Co., Lupin Limited, Endo Pharmaceuticals Inc., Aurobindo Pharma Limited, and Aspen Pharmacare Holdings Limited.

Key Questions Answered in This Report:

How has the market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global generic drugs market?
What are the major drug delivery segments?
What are the key therapy areas?
What are the major distribution channels?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the industry and who are the key players?
What is the degree of competition in the industry?
What are the profit margins in the industry?
What are the key requirements for setting up a manufacturing plant?
How are generic drugs manufactured?
What are the various unit operations involved in a manufacturing plant?
What is the total size of land required for setting up a manufacturing plant?
What are the machinery requirements for setting up a manufacturing plant?
What are the raw material requirements for setting up a manufacturing plant?
What are the packaging requirements for generic drugs?
What are the transportation requirements for generic drugs?
What are the utility requirements for setting up a manufacturing plant?
What are the manpower requirements for setting up a manufacturing plant?
What are the infrastructure costs for setting up a manufacturing plant?
What are the capital costs for setting up a manufacturing plant?
What are the operating costs for setting up a manufacturing plant?
What will be the income and expenditures for a manufacturing plant?
What is the time required to break-even?

【レポートの目次】

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Generic Drugs Industry
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Country
5.5 Market Breakup by Therapy Area
5.6 Market Breakup by Drug Delivery
5.7 Market Breakup by Distribution Channel
5.8 Market Forecast
5.9 SWOT Analysis
5.9.1 Overview
5.9.2 Strengths
5.9.3 Weaknesses
5.9.4 Opportunities
5.9.5 Threats
5.10 Value Chain Analysis
5.10.1 Research and Development
5.10.2 Manufacturing
5.10.3 Marketing and Distribution
5.11 Porter’s Five Forces Analysis
5.11.1 Overview
5.11.2 Bargaining Power of Buyers
5.11.3 Bargaining Power of Suppliers
5.11.4 Degree of Competition
5.11.5 Threat of New Entrants
5.11.6 Threat of Substitutes
5.12 Regulations in the Generic Industry
5.13 Key Market Drivers and Success Factors
6 Performance of Key Countries
6.1 United States
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 China
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Brazil
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Germany
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 France
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 India
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 United Kingdom
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Japan
6.8.1 Market Trends
6.8.2 Market Forecast
6.9 Canada
6.9.1 Market Trends
6.9.2 Market Forecast
6.10 Italy
6.10.1 Market Trends
6.10.2 Market Forecast
6.11 Others
6.11.1 Market Trends
6.11.2 Market Forecast
7 Market Breakup by Therapy Area
7.1 Central Nervous System
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cardiovascular
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Dermatology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Genitourinary/Hormonal
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Respiratory
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Rheumatology
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Diabetes
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 Oncology
7.8.1 Market Trends
7.8.2 Market Forecast
7.9 Others
7.9.1 Market Trends
7.9.2 Market Forecast
8 Market Breakup by Drug Delivery
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Injectables
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Dermal/Topical
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Inhalers
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Retail Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospital Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
10 Competitive Landscape
10.1 Competitive Structure
10.2 Market Breakup by Key Players
10.3 Key Player Profiles
10.3.1 Teva Pharmaceuticals Industries Ltd.
10.3.2 Mylan N.V.
10.3.3 Novartis AG
10.3.4 Pfizer Inc.
10.3.5 Sun Pharmaceutical Industries Ltd.
10.3.6 Fresenius SE & Co.
10.3.7 Lupin Limited
10.3.8 Endo Pharmaceuticals Inc.
10.3.9 Aurobindo Pharma Limited
10.3.10 Aspen Pharmacare Holdings Limited
11 Generic Drugs Manufacturing Process
11.1 Product Overview
11.2 Detailed Process Flow (Tablets)
11.3 Detailed Process Flow (Injectable)
11.4 Various Types of Unit Operations Involved
11.5 Mass Balance and Raw Material Requirements
12 Project Details, Requirements and Costs Involved
12.1 Land Requirements and Expenditures
12.2 Construction Requirements and Expenditures
12.3 Plant Machinery
12.4 Machinery Pictures
12.5 Raw Material Requirements and Expenditures
12.6 Packaging Requirements and Expenditures
12.7 Transportation Requirements and Expenditures
12.8 Utility Requirements and Expenditures
12.9 Manpower Requirements and Expenditures
12.10 Other Capital Investments
13 Loans and Financial Assistance
14 Project Economics
14.1 Capital Cost of the Project
14.2 Techno-Economic Parameters
14.3 Product Pricing and Margins Across Various Levels of the Supply Chain
14.4 Taxation and Depreciation
14.5 Income Projections
14.6 Expenditure Projections
14.7 Financial Analysis
14.8 Profit Analysis

Figure 1: Global: Generic Drugs Market: Major Drivers and Challenges
Figure 2: Global: Generic Drugs Market: Sales Value Trends (in Billion US$), 2015-2020
Figure 3: Global: Generic Drugs Market Forecast: Sales Value Trends (in Billion US$), 2021-2026
Figure 4: Global: Generic Drugs Market: Breakup by Country (in %), 2020
Figure 5: Global: Generic Drugs Market: Breakup by Therapy Area (in %), 2020
Figure 6: Global: Generic Drugs Market: Breakup by Drug Delivery (in %), 2020
Figure 7: Global: Generic Drugs Market: Breakup by Distribution Channel (in %), 2020
Figure 8: Global: Generic Drugs Industry: SWOT Analysis
Figure 9: Global: Generic Drugs Industry: Value Chain Analysis
Figure 10: Global: Generic Drugs Industry: Porter’s Five Forces Analysis
Figure 11: USA: Generic Drugs Market (in Million US$), 2015 & 2020
Figure 12: USA: Generic Drugs Market Forecast (in Million US$), 2021-2026
Figure 13: China: Generic Drugs Market (in Million US$), 2015 & 2020
Figure 14: China: Generic Drugs Market Forecast (in Million US$), 2021-2026
Figure 15: Brazil: Generic Drugs Market (in Million US$), 2015 & 2020
Figure 16: Brazil: Generic Drugs Market Forecast (in Million US$), 2021-2026
Figure 17: Germany: Generic Drugs Market (in Million US$), 2015 & 2020
Figure 18: Germany: Generic Drugs Market Forecast (in Million US$), 2021-2026
Figure 19: France: Generic Drugs Market (in Million US$), 2015 & 2020
Figure 20: France: Generic Drugs Market Forecast (in Million US$), 2021-2026
Figure 21: India: Generic Drugs Market (in Million US$), 2015 & 2020
Figure 22: India: Generic Drugs Market Forecast (in Million US$), 2021-2026
Figure 23: United Kingdom: Generic Drugs Market (in Million US$), 2015 & 2020
Figure 24: United Kingdom: Generic Drugs Market Forecast (in Million US$), 2021-2026
Figure 25: Japan: Generic Drugs Market (in Million US$), 2015 & 2020
Figure 26: Japan: Generic Drugs Market Forecast (in Million US$), 2021-2026
Figure 27: Canada: Generic Drugs Market (in Million US$), 2015 & 2020
Figure 28: Canada: Generic Drugs Market Forecast (in Million US$), 2021-2026
Figure 29: Italy: Generic Drugs Market (in Million US$), 2015 & 2020
Figure 30: Italy: Generic Drugs Market Forecast (in Million US$), 2021-2026
Figure 31: Global: Generic Drugs Market: Orals (in Million US$), 2015 & 2020
Figure 32: Global: Generic Drugs Market Forecast: Orals (in Million US$), 2021-2026
Figure 33: Global: Generic Drugs Market: Injectables (in Million US$), 2015 & 2020
Figure 34: Global: Generic Drugs Market Forecast: Injectables (in Million US$), 2021-2026
Figure 35: Global: Generic Drugs Market: Dermal/Topical (in Million US$), 2015 & 2020
Figure 36: Global: Generic Drugs Market Forecast: Dermal/Topical (in Million US$), 2021-2026
Figure 37: Global: Generic Drugs Market: Inhalers (in Million US$), 2015 & 2020
Figure 38: Global: Generic Drugs Market Forecast: Inhalers (in Million US$), 2021-2026
Figure 39: Global: Generic Drugs Market: Central Nervous System (in Million US$), 2015 & 2020
Figure 40: Global: Generic Drugs Market Forecast: Central Nervous System (in Million US$), 2021-2026
Figure 41: Global: Generic Drugs Market: Cardiovascular (in Million US$), 2015 & 2020
Figure 42: Global: Generic Drugs Market Forecast: Cardiovascular (in Million US$), 2021-2026
Figure 43: Global: Generic Drugs Market: Dermatology (in Million US$), 2015 & 2020
Figure 44: Global: Generic Drugs Market Forecast: Dermatology (in Million US$), 2021-2026
Figure 45: Global: Generic Drugs Market: Genitourinary/Hormonal (in Million US$), 2015 & 2020
Figure 46: Global: Generic Drugs Market Forecast: Genitourinary/Hormonal (in Million US$), 2021-2026
Figure 47: Global: Generic Drugs Market: Respiratory (in Million US$), 2015 & 2020
Figure 48: Global: Generic Drugs Market Forecast: Respiratory (in Million US$), 2021-2026
Figure 49: Global: Generic Drugs Market: Rheumatology (in Million US$), 2015 & 2020
Figure 50: Global: Generic Drugs Market Forecast: Rheumatology (in Million US$), 2021-2026
Figure 51: Global: Generic Drugs Market: Diabetes (in Million US$), 2015 & 2020
Figure 52: Global: Generic Drugs Market Forecast: Diabetes (in Million US$), 2021-2026
Figure 53: Global: Generic Drugs Market: Oncology (in Million US$), 2015 & 2020
Figure 54: Global: Generic Drugs Market Forecast: Oncology (in Million US$), 2021-2026
Figure 55: Global: Generic Drugs Market: Other Therapy Areas (in Million US$), 2015 & 2020
Figure 56: Global: Generic Drugs Market Forecast: Other Therapy Areas (in Million US$), 2021-2026
Figure 57: Global: Generic Drugs Market: Retail Pharmacies (in Million US$), 2015 & 2020
Figure 58: Global: Generic Drugs Market Forecast: Retail Pharmacies (in Million US$), 2021-2026
Figure 59: Global: Generic Drugs Market: Hospital Pharmacies (in Million US$), 2015 & 2020
Figure 60: Global: Generic Drugs Market Forecast: Hospital Pharmacies (in Million US$), 2021-2026
Figure 61: Generic Drugs Industry: Profit Margins at Various Levels of the Supply Chain
Figure 62: Generic Drugs Manufacturing: Production Cost Breakup (in %)
Figure 63: Generic Drugs Manufacturing: Detailed Process Flow
Figure 64: Generic Drugs Manufacturing Process: Conversion Rate of Feedstocks
Figure 65: Generic Drugs Manufacturing: Proposed Plant Layout
Figure 66: Generic Drugs Manufacturing Plant: Breakup of Capital Costs (in %)


Table 1: Global: Generic Drugs Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Generic Drugs Market Forecast: Breakup by Country (in Million US$), 2021-2026
Table 3: Global: Generic Drugs Market Forecast: Breakup by Therapy Area (in Million US$), 2021-2026
Table 4: Global: Generic Drugs Market Forecast: Breakup by Drug Delivery (in Million US$), 2021-2026
Table 5: Global: Generic Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 6: Generic Drugs Market: Competitive Structure
Table 7: Generic Drugs Market: Key Players
Table 8: Generic Drugs Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 9: Generic Drugs Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 10: Generic Drugs Manufacturing Plant: Costs Related to Machinery Unit (in US$)
Table 11: Generic Drugs Manufacturing Plant: Raw Material Requirements
Table 12: Generic Drugs Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 13: Generic Drugs Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 14: Details of Financial Assistance Offered by Financial Institutions
Table 15: Generic Drugs Manufacturing Plant: Capital Costs (in US$)
Table 16: Generic Drugs Manufacturing Plant: Techno-Economic Parameters
Table 17: Generic Drugs Manufacturing Plant: Taxation and Depreciation (in US$)
Table 18: Generic Drugs Manufacturing Plant: Income Projections (in US$)
Table 19: Generic Drugs Manufacturing Plant: Expenditure Projections (in US$)
Table 20: Generic Drugs Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability (in US$)
Table 21: Generic Drugs Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability (in US$)
Table 22: Generic Drugs Manufacturing Plant: Profit and Loss Account (in US$)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のジェネリック医薬品市場予測2021年-2026年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆